Kim et al. demonstrated a remarkably upregulated UBE2Z expression in 92.5% of tumor-normal paired samples derived from 106 lung cancer patients, whereas no change was observed in mRNA level [73]. The gene discussed is UBE2Z; the disease is lung carcinoma.